Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors

The results of a recent trial undoubtedly contribute a vital element to the overarching management of rare tumors and offer new treatment hopes for patients with brain metastases, thereby paving the way for future research in immunotherapy.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-03-09
DOI
https://doi.org/10.1158/1078-0432.ccr-25-4816
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors

Angela Dalia Ricci, Alessandro Rizzo
Clinical Cancer Research
Brain Metastases and Treatment
article

Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors

Angela Dalia Ricci, Alessandro Rizzo
article en

Abstract

The results of a recent trial undoubtedly contribute a vital element to the overarching management of rare tumors and offer new treatment hopes for patients with brain metastases, thereby paving the way for future research in immunotherapy.

Clinical Cancer Research
Istituto Tumori Bari (IT), Gastroenterology Hospital "Saverio de Bellis" (IT)
Good health and well-being
Openalex Percentile: Top 29%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors — Angela Dalia Ricci, Alessandro Rizzo · Clinical Cancer Research (2026) | TGRS Research Map | TGRS